A subset of diffuse-type gastric cancer is susceptible to mTOR inhibitors and checkpoint inhibitors

被引：0
|
作者：
Hiroshi Fukamachi
Seon-Kyu Kim
Jiwon Koh
Hye Seung Lee
Yasushi Sasaki
Kentaro Yamashita
Taketo Nishikawaji
Shu Shimada
Yoshimitsu Akiyama
Sun-ju Byeon
Dong-Hyuck Bae
Keisuke Okuno
Masatoshi Nakagawa
Toshiro Tanioka
Mikito Inokuchi
Hiroshi Kawachi
Kiichiro Tsuchiya
Kazuyuki Kojima
Takashi Tokino
Yoshinobu Eishi
Yong Sung Kim
Woo Ho Kim
Yasuhito Yuasa
Shinji Tanaka
机构：
[1] Tokyo Medical and Dental University,Department of Molecular Oncology, Graduate School of Medical and Dental Sciences
[2] Korea Research Institute of Bioscience and Biotechnology,Personalized Genomic Medicine Research Center
[3] Seoul National University Bundang Hospital,Department of Pathology
[4] Research Institute for Frontier Medicine,Medical Genome Sciences
[5] Sapporo Medical University School of Medicine,Department of Gastroenterology and Hepatology
[6] Sapporo Medical University School of Medicine,Department of Pathology
[7] Seoul National University College of Medicine,Genome Editing Research Center
[8] Korea Research Institute of Bioscience & Biotechnology,Department of Gastrointestinal Surgery, Graduate School of Medical and Dental Sciences
[9] Tokyo Medical and Dental University,Department of Human Pathology, Graduate School of Medical and Dental Sciences
[10] Tokyo Medical and Dental University,Department of Gastroenterology and Hepatology
[11] Tokyo Medical and Dental University,Center of Minimally Invasive Surgery, Graduate School of Medical and Dental Sciences
[12] Tokyo Medical and Dental University,Present Address: Division of Cancer Biology and Therapeutics
[13] Miyagi Cancer Center Research Institute,Present Address: Department of Pathology
[14] The Cancer Institute Hospital of the Japanese Foundation for Cancer Research,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
Diffuse-type gastric cancer; mTOR inhibitor; Temsirolimus; PIK3CA; Microsatellite unstable; Immune checkpoint inhibitor; PD-L1; Patient-derived xenograft; Primary culture;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Prostate stem cell antigen is associated with diffuse-type gastric cancer
    Nature Clinical Practice Oncology, 2008, 5 (9): : 498 - 499
  • [32] Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer
    Sakamoto, Hiromi
    Yoshimura, Kimio
    Saeki, Norihisa
    Katai, Hitoshi
    Shimoda, Tadakazu
    Matsuno, Yoshihiro
    Saito, Daizo
    Sugimura, Haruhiko
    Tanioka, Fumihiko
    Kato, Shunji
    Matsukura, Norio
    Matsuda, Noriko
    Nakamura, Tsuneya
    Hyodo, Ichinosuke
    Nishina, Tomohiro
    Yasui, Wataru
    Hirose, Hiroshi
    Hayashi, Matsuhiko
    Toshiro, Emi
    Ohnami, Sumiko
    Sekine, Akihiro
    Sato, Yasunori
    Totsuka, Hirohiko
    Ando, Masataka
    Takemura, Ryo
    Takahashi, Yoriko
    Ohdaira, Minoru
    Aoki, Kenichi
    Honmyo, Izumi
    Chiku, Suenori
    Aoyagi, Kazuhiko
    Sasaki, Hiroki
    Ohnami, Shumpei
    Yanagihara, Kazuyoshi
    Yoon, Kyong-Ah
    Kook, Myeong-Cherl
    Lee, Yeon-Su
    Park, Sook Ryun
    Kim, Chan Gyoo
    Choi, Il Ju
    Yoshida, Teruhiko
    Nakamura, Yusuke
    Hirohashi, Setsuo
    NATURE GENETICS, 2008, 40 (06) : 730 - 740
  • [33] The impact of RHOA mutation related with invasion in diffuse-type gastric cancer
    Eto, Tsugio
    Ishimoto, Takatsugu
    Izumi, Daisuke
    Tamaoki, Yuka
    Kuroda, Daisuke
    Arima, Kota
    Kaida, Takayoshi
    Ohuchi, Mayuko
    Nakamura, Kenichi
    Tokunaga, Ryunna
    Shigaki, Hironobu
    Kurashige, Junji
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Sakamoto, Yasuo
    Yoshida, Naoya
    Baba, Hideo
    CANCER RESEARCH, 2016, 76
  • [34] Endoscopic mucosal resection (EMR) for diffuse-type mucosal gastric cancer
    Inoue, M
    Gotoda, T
    Soetikno, RM
    Hamanaka, H
    Oda, I
    Saito, D
    GASTROINTESTINAL ENDOSCOPY, 2004, 59 (05) : AB170 - AB170
  • [35] Genomic characterization of life-cycle in diffuse-type gastric cancer
    Ishikawa, Shumpei
    CANCER SCIENCE, 2022, 113 : 1253 - 1253
  • [36] Subtotal versus total gastrectomy for distal diffuse-type gastric cancer
    Gajardo, Jorge A.
    Arriagada, Francisco J.
    Munoz, Florencia D.
    Veloso, Francisca A.
    Pacheco, Francisco A.
    Molina, Hector E.
    Schaub, Thomas P.
    Torres, Osvaldo A.
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2024, 38 (12): : 7588 - 7595
  • [37] Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer
    Nature Genetics, 2008, 40 : 730 - 740
  • [38] Blood neutrophil subset predicts the success of immune checkpoint inhibitors in cancer
    Bordon, Yvonne
    NATURE REVIEWS IMMUNOLOGY, 2024, 24 (02) : 89 - 89
  • [39] Blood neutrophil subset predicts the success of immune checkpoint inhibitors in cancer
    Yvonne Bordon
    Nature Reviews Immunology, 2024, 24 : 89 - 89
  • [40] Chondrosarcomatous Differentiation in Diffuse-Type Gastric Carcinoma
    Vincenzo Villanacci
    Marco Gambarotti
    Alessandro Ubiali
    Giancarlo Cervi
    Giuseppe Pulcini
    Vittorio De Cesare
    Gabrio Bassotti
    Digestive Diseases and Sciences, 2006, 51 : 1658 - 1661
12345